Compare SDHI & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SDHI | CADL |
|---|---|---|
| Founded | 2024 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 358.5M | 339.8M |
| IPO Year | 2025 | 2021 |
| Metric | SDHI | CADL |
|---|---|---|
| Price | $10.25 | $6.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $19.43 |
| AVG Volume (30 Days) | 164.9K | ★ 731.5K |
| Earning Date | 01-01-0001 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.00 | $4.25 |
| 52 Week High | $10.45 | $13.68 |
| Indicator | SDHI | CADL |
|---|---|---|
| Relative Strength Index (RSI) | 49.22 | 54.07 |
| Support Level | $10.24 | $5.91 |
| Resistance Level | $10.30 | $6.62 |
| Average True Range (ATR) | 0.02 | 0.36 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 37.50 | 51.60 |
Siddhi Acquisition Corp is a blank check company.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.